Medical Condition News

RSS
BIOTRONIK launches new Renamic implantable cardiac device in Europe

BIOTRONIK launches new Renamic implantable cardiac device in Europe

DNA methylation patterns can accurately detect early bowel cancer

DNA methylation patterns can accurately detect early bowel cancer

VICC introduces nation's first personalized cancer decision support tool

VICC introduces nation's first personalized cancer decision support tool

BMC partners with YMCA of Greater Boston to form END Diabetes Program

BMC partners with YMCA of Greater Boston to form END Diabetes Program

New study provides fascinating insight into genetic basis of bipolar disorder

New study provides fascinating insight into genetic basis of bipolar disorder

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies

Eisai receives FDA approval for BANZEL Oral Suspension to treat seizures linked with LGS

Eisai receives FDA approval for BANZEL Oral Suspension to treat seizures linked with LGS

Scientists uncover genetic pathway that affects breast cancer development

Scientists uncover genetic pathway that affects breast cancer development

Racial and ethnic groups less likely to receive kidney transplants than others

Racial and ethnic groups less likely to receive kidney transplants than others

Neurodegenerative Disease Management – meeting the challenge of neurodegenerative diseases

Neurodegenerative Disease Management – meeting the challenge of neurodegenerative diseases

Ventus Medical's Provent Sleep Apnea Therapy granted CE Mark

Ventus Medical's Provent Sleep Apnea Therapy granted CE Mark

Glenmark Generics granted final FDA approval for generic Xyzal ANDA

Glenmark Generics granted final FDA approval for generic Xyzal ANDA

Protalex initiates enrollment in 3rd cohort of PRTX-100 Phase 1b dose escalation clinical study in RA

Protalex initiates enrollment in 3rd cohort of PRTX-100 Phase 1b dose escalation clinical study in RA

Infinity commences IPI-926 Phase 2 clinical trial in rare, life-threatening bone cancer

Infinity commences IPI-926 Phase 2 clinical trial in rare, life-threatening bone cancer

EC grants marketing authorization for InterMune's Esbriet to treat IPF

EC grants marketing authorization for InterMune's Esbriet to treat IPF

Sarsia grants BerGenBio NOK7 million to continue CellSelect advanced technology platform

Sarsia grants BerGenBio NOK7 million to continue CellSelect advanced technology platform

ContextVision launches MAMMO PlusViewCAD breast cancer detection tool at ECR

ContextVision launches MAMMO PlusViewCAD breast cancer detection tool at ECR

ContextVision launches GOPView iRVUltra product at 2011 ECR annual meeting

ContextVision launches GOPView iRVUltra product at 2011 ECR annual meeting

New insight: p53 protein controls molecular crossroads in glucose metabolic pathway

New insight: p53 protein controls molecular crossroads in glucose metabolic pathway

New discovery in glioma-associated metabolic changes

New discovery in glioma-associated metabolic changes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.